journal article·2026-03-01

Niche-targeted paracrine signaling from OMSCs restores the regenerative microenvironment after SCI

Zhe Wang, Ruijie Feng, Wanjing Rong, Xu Shi, Qingtong Yu, Wenwen Deng, Xia Cao, Qilong Wang, Jollibekov Berdiyar, Mohammad Had Eskandari, Jiangnan Yu, Ximing Xu

Biofabrication· Volume 18· Issue 1
Publisher page

Abstract

Abstract A central hurdle in spinal cord injury (SCI) therapy involves not only reconstructing neural pathways but also overcoming the detrimental inflammatory milieu. Inspired by olfactory microenvironmental niches, we implemented a niche-targeted strategy. Our investigation defines the biological properties of ectodermal olfactory mesenchymal stem cells (OMSCs) and further elucidates their niche-targeted paracrine effect in vivo and in vitro . The findings demonstrate that OMSC-conditioned medium (OMSC-CM) delivered in fibrin hydrogel mediates potent SCI repair by concurrently protecting neurons, enhancing axonal regeneration, and suppressing destructive inflammation via IL-10 signaling. Critically, persistence of IL-10 signaling in vivo is sustained both by direct supply from OMSC-CM and by OMSC-CM-induced activation of CD206 + macrophages IL−10 . Successful neural circuit reconstruction with OMSC-CM depends on maximizing neuronal involvement in neural pathway formation. These findings may establish a special conceptual framework for developing regenerative medicine strategies in the future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nerve injury and regeneration · Neurogenesis and neuroplasticity mechanisms · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (58)

Show source-provided references
1. Exosomes: a promising microenvironment modulator for spinal cord injury treatment10.7150/ijbs.115242 ↗
2. Functional biomaterials for modulating the dysfunctional pathological microenvironment of spinal cord injury10.1016/j.bioactmat.2024.04.015 ↗
3. Olfactory receptors in neural regeneration in the central nervous system10.4103/NRR.NRR-D-24-00495 ↗
4. Neuronal plasticity and regeneration in the olfactory system of mammals: morphological and functional recovery following olfactory bulb deafferentation10.1007/PL00000879 ↗
5. Adult neurogenesis and the olfactory system10.1016/j.pneurobio.2009.07.003 ↗
6. Olfactory mucosa: a rich source of cell therapy for central nervous system repair10.1515/revneuro-2014-0065 ↗
7. Adult human nasal mesenchymal stem cells have an unexpected broad anatomic distribution10.1002/alr.21153 ↗
8. Isolation and characterization of cat olfactory ecto-mesenchymal stem cells10.3390/ani12101284 ↗
9. Human nasal olfactory stem cells, purified as advanced therapy medicinal products, improve neuronal differentiation10.3389/fnins.2022.1042276 ↗
10. Isolation and characterization of olfactory ecto-mesenchymal stem cells from eight mammalian genera10.1186/s12917-018-1342-2 ↗
11. Mesenchymal stromal cell-based products: challenges and clinical therapeutic options10.3390/ijms25116063 ↗
12. Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: risk-benefit profile and next steps for the market access10.1016/j.bioactmat.2023.06.013 ↗
13. Mesenchymal stem cell secretome for regenerative medicine: where do we stand?10.1016/j.jare.2024.05.004 ↗
14. Myostatin regulates energy homeostasis through autocrine- and paracrine-mediated microenvironment communication10.1172/JCI178303 ↗
15. Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication10.1016/j.cmet.2025.06.009 ↗
16. Cancer neuroscience: state of the field, emerging directions10.1016/j.cell.2023.02.002 ↗
17. Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells10.1038/s41584-023-01010-7 ↗
18. Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies10.1002/adhm.202001689 ↗
19. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration10.1186/s12967-021-03125-5 ↗
20. Microelectrode arrays measure blocking of voltage-gated calcium ion channels on supported lipid bilayers derived from primary neurons10.1002/advs.202304301 ↗
21. Fisetin promotes functional recovery after spinal cord injury by inhibiting microglia/macrophage M1 polarization and JAK2/STAT3 signaling pathway10.1021/acs.jafc.4c02985 ↗
22. LBO-EMSC hydrogel serves a dual function in spinal cord injury restoration via the PI3K-Akt-mTOR pathway10.1021/acsami.1c12013 ↗
23. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains10.1089/neu.2006.23.635 ↗
24. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
25. The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer10.3892/ol.2019.10106 ↗
26. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma10.3892/ijo.2014.2278 ↗
27. Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics10.1016/j.jcyt.2024.10.008 ↗
28. PC-12 cell line as a neuronal cell model for biosensing applications10.3390/bios12070500 ↗
29. Blood-spinal cord barrier in spinal cord injury: a review10.1089/neu.2020.7413 ↗
30. Autologous fibrin glue: the last step in operative hemostasis10.1016/S0002-9610(94)80049-9 ↗
31. The role of inflammatory cascade and reactive astrogliosis in glial scar formation post-spinal cord injury10.1007/s10571-024-01519-9 ↗
32. The role of Interleukin-10 in the pathogenesis and treatment of a spinal cord injury10.3390/diagnostics14020151 ↗
33. Advances in the research of the role of macrophage/microglia polarization-mediated inflammatory response in spinal cord injury10.3389/fimmu.2022.1014013 ↗
34. NT3-chitosan elicits robust endogenous neurogenesis to enable functional recovery after spinal cord injury10.1073/pnas.1510194112 ↗
35. Remodeling microenvironment for endogenous repair through precise modulation of chondroitin sulfate proteoglycans following spinal cord injury10.1002/smll.202205012 ↗
36. Contribution of olfactory neural stem cells to tissue maintenance and regeneration10.1038/nn1882 ↗
37. Stem and progenitor cells of the mammalian olfactory epithelium: taking poietic license10.1002/cne.24105 ↗
38. Olfactory mucosa for transplant-mediated repair: a complex tissue for a complex injury10.1002/glia.20917 ↗
39. Secretome of olfactory mucosa mesenchymal stem cell, a multiple potential stem cell10.1155/2016/1243659 ↗
40. Differential expression of CXCL12 and CXCR4 during human fetal neural progenitor cell differentiation10.1007/s11481-007-9081-3 ↗
41. Chemokine signaling is required for homeostatic and injury-induced neurogenesis in the olfactory epithelium10.1002/stem.3338 ↗
42. Nestin-expressing progenitor cells: function, identity and therapeutic implications10.1007/s00018-018-2794-z ↗
43. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration10.1186/s12974-021-02337-2 ↗
44. Interleukin-10 signaling in somatosensory neurons controls CCL2 release and inflammatory response10.1016/j.bbi.2023.12.013 ↗
45. Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury10.34133/research.0056 ↗
46. A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury10.1016/j.biomaterials.2021.121279 ↗
47. Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages10.1186/s11658-022-00325-9 ↗
48. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair10.1016/j.tins.2012.06.003 ↗
49. Comparison of mesenchymal stromal cells isolated from murine adipose tissue and bone marrow in the treatment of spinal cord injury10.1177/0963689718780309 ↗
50. Prospect of stem cell conditioned medium in regenerative medicine10.1155/2014/965849 ↗
51. Conditioned medium—is it an undervalued lab waste with the potential for osteoarthritis management10.1007/s12015-023-10517-1 ↗
52. Hitting the target: cell signaling pathways modulation by extracellular vesicles10.20517/evcna.2024.16 ↗
53. Exosome-based therapy for spinal cord injury: a narrative review10.4103/ATN.ATN-D-25-00001 ↗
54. Stem cell-derived extracellular vesicle-mediated therapeutic signaling in spinal cord injury10.3390/ijms26020723 ↗
55. Therapeutic potential of mesenchymal stem cell-derived exosomes in spinal cord injury10.1007/s12035-024-04490-0 ↗
56. Inhibition of ferroptosis by mesenchymal stem cell-derived exosomes in acute spinal cord injury: role of Nrf2/GCH1/BH4 axis10.14245/ns.2448038.019 ↗
57. Application and mechanism of cell therapy technology in the repair of spinal cord injury: a narrative review10.4103/ATN.ATN-D-24-00008 ↗
58. Engineering multifunctional adhesive hydrogel patches for biomedical applications10.1002/INMD.20230008 ↗